BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, originally derived from a partial sequence of a protein identified in human gastric juice. Published in vitro and animal model research has examined its interactions with angiogenic signaling pathways, including modulation of vascular endothelial growth factor (VEGF) receptor expression and nitric oxide synthase activity in controlled experimental systems. Additional studies have characterized its influence on fibroblast and tendon cell migration markers, as well as growth hormone receptor upregulation, in preclinical tissue repair research contexts.
\n
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | CAS: 137525-51-0 | MW: 1419.55 g/mol
\n
Purity: ≥98% (HPLC) | Format: Lyophilized powder | Storage: −20°C, desiccated, protected from light
\n
Reconstitution: Bacteriostatic water recommended for research use
\n
\n
⚠️ Research Use Only. This compound is intended exclusively for qualified in vitro and laboratory research. It is not approved for human consumption, is not a dietary supplement, and has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or health condition. Researchers are solely responsible for compliance with all applicable federal, state, and local laws governing research chemical use.
